Scabies is a contagious disease caused by the mite Sarcoptes scabiei var hominis.
The affected individual usually complains of having a highly pruritic rash that occurs at night.
It occurs more often in children <15 years of age, sexually active young adults, the immunocompromised and in persons living in crowded living conditions (eg nursing homes, military barracks).
Transmission is typically by direct skin contact with an infected person and in adults, sexual transmission is common.

Scabies Treatment


Keratolytics (Topical)

  • The removal of crust and scales with keratolytics is necessary for scabicide penetration of crusted scabies

Ivermectin (Oral)

  • Effective treatment option for scabies patients unresponsive to 1st-line/2nd-line treatment
  • Combination therapy with topical scabicides is considered to be the best option for crusted scabies
  • May have a role in the treatment of refractory infestations and immunocompromised patients, or when administration of head-to-toe topical therapy would be difficult
    • May also be used in scabies epidemics in institutions
  • Interrupts gamma-aminobutyric acid (GABA)-induced neurotransmission of many parasites
  • Efficacy is comparable with topical Permethrin and more superior than Lindane

Scabicides (Topical)

Benzyl Benzoate

  • Effective in the management of Permethrin-resistant crusted scabies
  • Different treatment regimens have been used but no comparative data have been published
  • May be used alone or in combination with Sulfiram
  • Maybe used with Ivermectin for patients with relapses after single treatment of Ivermectin


  • May be useful for the treatment of nodule scabies in children but may require up to 5 days of treatment
  • May be used for symptomatic relief from pruritus but there is conflicting evidence of its efficacy
  • Appears to be less effective as a scabicide than Permethrin and Lindane


  • 1% lotion was reported to be as effective as 5% Permethrin cream

Lindane (Gamma Benzene Hexachloride)

  • Used only as an alternative therapy in patients intolerant of other therapies or when other therapies fail due to risk of neurotoxicity
  • When used properly, it is an effective scabicide
    • 1% formulation is usually effective after a single 6-hour treatment
  • Lindane-resistant scabies has been noted in North, Central and South America and in Asia
  • Not recommended in patients with crusted scabies due to risk of toxicity


  • Overnight application of 5% aqueous preparation is an effective treatment option
  • Alternative for patients where treatment with Permethrin is not appropriate


  • Recommended 1st-line treatment for children and adults including pregnant and lactating women
  • Has been shown to be as effective as Lindane and more effective than Crotamiton
  • Impairs function of voltage-gated sodium channels in insects which leads to disruption of neurotransmission
  • Has low toxicity


  • The oldest known treatment for scabies
  • Safe and effective, but requires application on 3 consecutive days
  • Treatment option for infants and pregnant women with scabies
  • Reproduction studies have not been conducted


  • May also be used to treat human scabies
    • Soap-containing monosulfiram have been used in the past as a prophylaxis for scabies

Other therapies

  • Nodular scabies may be treated with corticosteroids after completed scabicide therapy
  • Oral antihistamines may be given to help alleviate pruritus
  • Medium- or high-potency topical steroids may also be given to help control pruritus after scabicide therapy
  • Secondary infections should be treated with appropriate antibiotics
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Tristan Manalac, 18 Nov 2020
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).
Pank Jit Sin, 13 May 2020
A trial vaccine for the prevention of COVID-19 is underway with the first US participants being dosed in the Phase 1/2 clinical trial. Known as the BNT162 vaccine programme, the trials are a collaboration between Pfizer Inc. and BioNTech SE, and is part of a global development programme with Germany and the US taking the lead in having the first cohorts to be vaccinated. Germany started the study 1 week earlier. 
Jairia Dela Cruz, 18 Dec 2020
Rinsing with mouthwash that contains povidone-iodine (PI) or cetylpyridinium chloride (CPC) helps reduce SARS-CoV-2 levels in the saliva of COVID-19 patients, with the effect persisting for up to 6 hours, as shown in a study from Singapore.